Option
Heim KI-Prompt-Liste Philosophie/Religion Täglicher Leitfaden für konfuzianische Selbstkultivierung

Täglicher Leitfaden für konfuzianische Selbstkultivierung

{:__('collect %s',Täglicher Leitfaden für konfuzianische Selbstkultivierung)}

Zerlege Kernprinzipien der konfuzianischen Selbstkultivierung für modernes Leben, erstelle praktizierbare Methoden für Normalbürger, hilft bei der Verbesserung der Selbstkultivierung im heutigen Leben.

Prompt-Inhalt Kopieren Kopieren

Combine the daily routine and life scenarios of ordinary modern urban people, break down the three core principles of Confucian self-cultivation: self-restraint, vigilance in solitude, and self-reflection, sort out actionable practices that do not require a large amount of special time and fit the modern pace, helping people steadily improve personal cultivation and reconcile their inner state in daily work and life.

Kopieren Kopieren

Ausgehend von dem täglichen Ablauf und Lebenssituationen gewöhnlicher moderner Stadtbewohner zerlege die drei Kernprinzipien der konfuzianischen Selbstkultivierung: Selbstbeherrschung, Wachsamkeit in Einsamkeit und Selbstreflexion, erstelle praktikable Praktiken, die keine große Sonderzeit erfordern und zum modernen Lebensrhythmus passen, helfen Menschen, ihre persönliche Kultivierung stetig zu verbessern und ihren inneren Zustand im täglichen Arbeit und Leben auszugleichen.

Kopieren Kopieren
Kommentare (0)
0/300

Empfehlung

Ethische Entscheidungsunterstützung
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers minor but non-fatal side effects during clinical trials that may affect long-term patient quality of life, yet the drug can save thousands of lives with no alternatives. Combine the utilitarian principle of maximizing happiness with the deontological principle of respecting life to analyze whether clinical trials should proceed, and provide balanced advice considering legal compliance, public trust, and patient rights, avoiding absolute moral judgments in favor of a stakeholder-based decision path.
Ethische Entscheidungsunterstützung
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug discovers minor but long-term side effects in clinical trials, while a competitor is about to launch a similar product. Please evaluate whether to disclose data early and delay launch by balancing utilitarian considerations of the greatest good for the greatest number against deontological duties regarding patient informed consent and corporate integrity. Provide a comprehensive report including risk assessment, stakeholder impact analysis, and final action recommendations, ensuring the decision aligns with legal compliance while reflecting the company's social responsibility and long-term values.
Ethische Entscheidungsunterstützung
Act as a senior corporate ethics consultant to deeply analyze the current business decision dilemma using a dual framework of utilitarianism and deontology. First, identify key stakeholders involved and their potential rights infringements, then evaluate the balance between long-term social impacts and short-term commercial benefits of different action plans. Avoid simple binary judgments; instead, provide a structured ethical risk assessment report pointing out potential moral pitfalls and offering optimization suggestions that align with corporate social responsibility standards, ensuring the final plan pursues profit without violating basic human values and legal bottom lines.
Ethische Entscheidungsunterstützung
Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.
Ethische Entscheidungsunterstützung
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.
Ethische Entscheidungsunterstützung
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.
OR